|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 201.55 USD | -0.57% |
|
-2.44% | -11.79% |
| 05:15pm | Ireland's fiscal success faces the risk of over-reliance |  |
| 05-05 | AbbVie Inc. Presents New Long-Term Data For Skyrizi And Rinvoq In Inflammatory Bowel Diseases | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 356B | |||||
| 846B | |||||
| 533B | |||||
| 324B | |||||
| 282B | |||||
| 278B |
- Stock Market
- Equities
- ABBV Stock
- Charts AbbVie Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition